louisiana semaglutide diarrhea class action Wegovy Lawsuit Over Gastroparesis Ozempic® Lawsuit | July 2026

Understanding Semaglutide: A Weight Loss Game-Changer What is semaglutide

Target 0.5-1 grams of protein per pound of body weight daily

EVOLUTION OF GLP-1 THERAPY Despite the considerable momentum to acclaim GLP-1 as a preferred first-line injection therapy for the treatment of type 2 diabetes, other routes of administration than injections have long been pursued

Loss of hair on the arms and legs and under the arms can also bring into question whether thyroid function may be involved

NICE recommends these early in treatment for many people with established cardiovascular disease or chronic kidney disease [3] Pioglitazone : An insulin sensitiser, though less commonly used due to side effects including weight gain and fluid retention DPP-4 inhibitors : These enhance incretin activity with a lower side effect burden than GLP-1 agonists but less weight loss benefit Tirzepatide : A newer dual GIP/GLP-1 receptor agonist available for type 2 diabetes (subject to local formulary approval) [3] For patients who cannot tolerate or do not respond adequately to Ozempic, other GLP-1 receptor agonists such as dulaglutide (Trulicity) or liraglutide (Victoza) may be considered

Semaglutide should generally be stopped at least two months before a planned pregnancy